Literature DB >> 31121314

Medical pathways of children with juvenile idiopathic arthritis before referral to pediatric rheumatology centers.

Caroline Freychet1, Céline Lambert2, Bruno Pereira2, Jean L Stephan3, Stéphane Echaubard4, Etienne Merlin4, Aurélie Chausset4.   

Abstract

OBJECTIVE: A better understanding about the referral pathway of patients suffering from juvenile idiopathic arthritis (JIA) is required The aim of this study was to describe and analyze time from onset of symptoms to first pediatric rheumatology (PR) visit and the referral pathway of children with incident JIA in two French competence centers.
METHODS: From October 2009 to October 2017, new JIA patients were registered in the "Auvergne-Loire cohort on JIA". We collected referral pathway, symptom onset, biological and clinical data at first assessment in PR department.
RESULTS: In all, 111 children were included. Median time to first PR visit was 3.3 months [interquartile range (IQR) 1.3, 10.7] with a significant difference between JIA subtypes. After exclusion of systemic JIA, older age at onset of symptoms, and presence of enthesitis or joint pain were significantly associated with a longer time to first PR visit, while joint swelling or limping, abnormal ESR or CRP were associated with a shorter time. The median number of health care practitioners met was 3 [IQR 3, 4]. Orthopedists referred children to a PR center in 64% of cases, pediatricians in 50%, emergency care practitioners in 27% and general practitioners in 25%. Although non-systemic JIAs are not an emergency, 45% were referred to the emergency room.
CONCLUSION: Time to first PR visit is rather short compared to other countries but remains too long. Pediatric rheumatologists should offer primary care providers basic training on JIA and fast direct access to PR departments if JIA is suspected.
Copyright © 2019 Société française de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Access to care; Juvenile idiopathic arthritis; Pediatric rheumatology; Referral pathway

Mesh:

Substances:

Year:  2019        PMID: 31121314     DOI: 10.1016/j.jbspin.2019.04.014

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  3 in total

1.  Factors impacting referral of JIA patients to a tertiary level pediatric rheumatology center in North India: a retrospective cohort study.

Authors:  Manjari Agarwal; Caroline Freychet; Sumidha Jain; Abhay Shivpuri; Anju Singh; Veronique Dinand; Sujata Sawhney
Journal:  Pediatr Rheumatol Online J       Date:  2020-03-04       Impact factor: 3.054

2.  Patient factors associated with waiting time to pediatric rheumatologist consultation for patients with juvenile idiopathic arthritis.

Authors:  Claire E H Barber; Cheryl Barnabe; Susanne Benseler; Ricky Chin; Nicole Johnson; Nadia Luca; Paivi Miettunen; Marinka Twilt; Dwaraka Veeramreddy; Natalie J Shiff; Heinrike Schmeling
Journal:  Pediatr Rheumatol Online J       Date:  2020-03-06       Impact factor: 3.054

3.  Genomic risk scores for juvenile idiopathic arthritis and its subtypes.

Authors:  Rodrigo Cánovas; Joanna Cobb; Marta Brozynska; John Bowes; Yun R Li; Samantha Louise Smith; Hakon Hakonarson; Wendy Thomson; Justine A Ellis; Gad Abraham; Jane E Munro; Michael Inouye
Journal:  Ann Rheum Dis       Date:  2020-09-04       Impact factor: 19.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.